Kate Rosenbluth
CEO
Bioengineering
Cala Health Ltd.
United States of America
Biography
Kate Rosenbluth PhD co-founded Cala Health to translate the latest neuroscience innovations into accessible therapies. She was an Innovation Fellow in Stanford Biodesign, Adjunct Faculty in Stanford Technology Ventures Program and a Postdoctoral Fellow in UCSF Neurosurgery. She has developed cutting-edge neurotherapies with Brainlab, Autonomic Technologies, and Genentech, authored numerous patents and published 30+ peer-reviewed papers. She holds a PhD in Bioengineering from UC Berkeley and UCSF and a BS in Mechanical Engineering at Stanford University.
Research Interest
Bioengineering
